Strategies of Natural Killer Cell Recognition and Signaling
- 1 January 2006
- book chapter
- Published by Springer Nature
- Vol. 298, 1-21
- https://doi.org/10.1007/3-540-27743-9_1
Abstract
The participation of natural killer (NK) cells in multiple aspects of innate and adaptive immune responses is supported by the wide array of stimulatory and inhibitory receptors they bear. Here we review the receptor-ligand interactions and subsequent signaling events that culminate in NK effector responses. Whereas some receptor-ligand interactions result in activation of both NK cytotoxicity and cytokine production, others have more subtle effects, selectively activating only one pathway or having distinct context-dependent effects. Recent approaches offer ways to unravel how the integration of complex signaling networks directs the NK response.Keywords
This publication has 115 references indexed in Scilit:
- The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAMBlood, 2005
- Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirusNature Immunology, 2005
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005
- Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defectBlood, 2004
- Natural killer cell activation in mice and men: different triggers for similar weapons?Nature Immunology, 2002
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated CytolysisAnnual Review of Immunology, 2001
- Regulation of p38 mitogen-activated protein kinase during NK cell activationEuropean Journal of Immunology, 2000
- Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49CEuropean Journal of Immunology, 1999
- The Vav–Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated KillingThe Journal of Experimental Medicine, 1998